Navigation Links
DNA vaccine for ragweed allergies

A recent research reported that ragweed or hay fever symptoms could be reduced by 60% with the help of an experimental //DNA-based vaccine developed at Johns Hopkins in Baltimore.

Dr. Peter Socrates Creticos, medical director of the Johns Hopkins Asthma and Allergy Center at the Johns Hopkins University School of Medicine and his team tested the DNA vaccine during two fall ragweed seasons in Baltimore.

The study was conducted on 25 volunteers with known allergies to ragweed of the ages 23-60 years. In the first year of the study, 14 people were given six weekly injections of the new vaccine before the ragweed season began. The remaining 11 received six weekly injections of a placebo.

The symptoms like sneezing, runny nose, watery eyes, and itching had reduced by 60% in people who received the vaccine. This relief was found to be steady even in the second year without the administration of the vaccine.

The Immune Tolerance Network funded this study. The National Institute of Allergy and Infectious Diseases and the National Institute of Diabetes and Digestive and Kidney Diseases are supporting this network.

Dynavax Technologies Corp. of Berkeley, Calif manufactures this DNA-based vaccine. It comprises a DNA sequence obtained from bacteria to shut down the T-helper (Th2) cells that trigger the body's inflammatory immune responses.

The study has been published in the October 5 issue of the New England Journal of Medicine. Creticos said, "I don’t expect any serious long-term side effects because this vaccine restores normalcy. The vaccine is so specific, only targeting the ragweed allergy; there likely won't be any long-term adverse effects. In fact, the vaccine is so specific that people who were vaccinated and who also have grass allergies in the spring still experienced symptoms from that particular allergy. "

He said, "The next step for this vaccine is phase III trials, after which the vaccine c ould receive government approval if all goes well. It could potentially become commercially available a few years down the road."
GYT
'"/>




Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2016)... Los Angeles, CA (PRWEB) , ... May 23, 2016 , ... ... bariatric surgeons have noted that, less than 1% of United Kingdom residents who could ... the UK’s National Health Service (NHS) increases the number of bariatric procedures it offers ...
(Date:5/23/2016)... ... ... Researchers can find themselves in a state of semi-autopilot while pipetting, perhaps ... yield big benefits. Scientists might be surprised to learn how acquiring specific pipetting techniques ... the risk of contamination when working with eukaryotic cells. , Eppendorf is sponsoring a ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... objectification, according to Georgia State University researchers. , In a recent ... fifth, sixth and seventh grades shared their experiences with strained relationships, recurring ...
(Date:5/23/2016)... Austin, Texas (PRWEB) , ... May 23, 2016 ... ... May 23, the Texas Veterinary Medical Association (TVMA) reminds pet owners that intervening ... a serious emergency. Heatstroke occurs when a pet’s normal body mechanisms cannot keep ...
(Date:5/23/2016)... ... 23, 2016 , ... ComplianceOnline, the leading governance, risk and compliance advisory network ... September 15 and 16, 2016 in San Diego, CA. The two day summit ... be one of the largest gatherings of medical device companies, suppliers, professionals and experts ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 2016 Gamida Cell, a leader ... cancer and orphan genetic diseases, announced today it has ... from the Israel Innovation Authority (formerly the Office of ... and Industry. The mission of the Israel Innovation Authority ... including science and technology, while stimulating economic growth. ...
(Date:5/20/2016)... , May 20, 2016 ... veteran investors believe that the industry is not far ... and today ActiveWallSt.com featured the following four equities: Anacor ... (NASDAQ: ATHX ), Aralez Pharmaceuticals Inc. (NASDAQ: ... INFI ). Sign up for your free ...
(Date:5/19/2016)... PARIS , May 19,2016 ... Activities at Digestive Disease Week Meeting and 91 ... Society Mauna Kea Technologies (Euronext: MKEA, ... laser endomicroscopy platform, today announced that its Cellvizio ... meeting focused on gastroenterology during the month of ...
Breaking Medicine Technology: